Reported 85,538 shares, down 17,865 (17.3%) from the prior quarter.
Reported value -61.8%; share count -17.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 115000 |
| 2022-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2022 | Reduced | 0 | -85,538 (-100.0%) | 0 | $0 | 2022-05-16 | |
| Q4 2021 | Reduced | 85,538 | -17,865 (-17.3%) | < 0.01% | $115,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
67 managers reported ODONATE THERAPEUTICS INC COM ( for Q4 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | Reduced | 12,767,435 | -2,747,131 | 3.47% | $17,236,000 | 17 qtrs |
| Boxer Capital LLC | Reduced | 4,207,086 | -1,400,000 | 0.22% | $5,680,000 | 17 qtrs |
| Ikarian Capital LLC | Reduced | 1,340,631 | -500,000 | 0.27% | $1,810,000 | 4 qtrs |
| VANGUARD GROUP INC | Added | 964,818 | +2,619 | < 0.01% | $1,302,000 | 17 qtrs |
| Samsara BioCapital LLC | Unchanged | 700,421 | 0 | 0.18% | $946,000 | 13 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Added | 416,739 | +51,186 | < 0.01% | $561,000 | 4 qtrs |
| BlackRock Inc | Reduced | 400,914 | -330,583 | < 0.01% | $541,000 | 16 qtrs |
| D E Shaw & Co Inc | Added | 374,195 | +140,855 | < 0.01% | $505,000 | 10 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 352,814 | +4,381 | < 0.01% | $476,000 | 16 qtrs |
| MYDA Advisors LLC | Added | 350,065 | +260,091 | 0.13% | $473,000 | 2 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2021
- Filed
- February 14, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 85,538
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.